Analysis of patients with endometrial carcinoma using the ProMise classifier: a pilot study from India.
Alka DahiyaAbarna RajaduraiSherin DanielAjit SebastianDhanya Susan ThomasVinotha ThomasRachel GeorgeThomas Samuel RamArvind SathyamurthyGrace RebekahAbraham PeedicayilRekha PaiAnitha ThomasPublished in: Archives of gynecology and obstetrics (2023)
The integration of molecular-clinicopathologic data for endometrial cancer classification, through cost-effective, clinically applicable assays appears to be a highly objective tool that can be adopted even in resource-limited settings. It has the potential to cause a shift in the paradigm of EC pathology and management practice.